Adult neurogenesis, the generation of new neurons during the adulthood, is a process controlled by several kinases and phosphatases among which GSK3b exerts important functions. This protein is particularly abundant in the central nervous system, and its activity deregulation is believed to play a key role in chronic disorders such as Alzheimer's disease. Previously, we reported that in vivo overexpression of GSK3b (Tet/ GSK3b mice) causes alterations in adult neurogenesis, leading to a depletion of the neurogenic niches. Here, we have further characterized those alterations, finding a delay in the switching-off of doublecortin marker as well as changes in the survival and death rates of immature precursors and a decrease in the total number of mature neurons. Besides, we have highlighted the importance of the inflammatory environment, identifying eotaxin as a possible modulator of the detrimental effects on adult neurogenesis. Taking advantage of the conditional system, we have also explored whether these negative consequences of increasing GSK3 activity are susceptible to revert after doxycycline treatment. We show that transgene shutdown in symptomatic mice reverts microgliosis, abnormal eotaxin levels as well as the aforementioned alterations concerning immature neurons. Unexpectedly, the decrease in the number of mature neurons and neuronal precursor cells of the subgranular zone of Tet/GSK3b mice could not be reverted. Thus, alterations in adult neurogenesis and likely in neurodegenerative disorders can be restored in part, although neurogenic niche depletion represents a non-reversible damage persisting during lifetime with a remarkable impact in adult mature neurons.
INTRODUCTION
Adult neurogenesis is a process that occurs in mammals, principally in two brain regions: the subventricular zone and the subgranular zone (SGZ) of the hippocampus. The stem cells that exist in both areas are a subset of astrocytes (1) . In the SGZ, astrocytes (type B cells) divide to generate intermediate precursors (type D cells), which remain in clusters of two to four cells in neurogenic niches that are formed by the processes of astrocytes (2) . Type D cells progressively generate more differentiated progeny, which eventually mature into granule neurons. New neurons that integrate in the hippocampus play important roles in aspects of learning and memory (3, 4) . The magnitude of neurogenesis declines with age, raising the possibility that reduced neurogenesis may account, to some degree, for the impaired learning and memory and cognitive deterioration in the elderly (5, 6) . Furthermore, adult neurogenesis is altered in many neurodegenerative diseases (reviewed in 7). In Alzheimer's disease (AD), an increase of the process has been observed (8) , although it has not been demonstrated that precursor cells finally become mature neurons. In general, adult neurogenesis defects appear before cognitive alterations do, making markers † These authors contributed equally to this work. * To whom correspondence should be addressed at: Centro de Biología Molecular Severo Ochoa, CSIC/UAM, Madrid, C/ Nicolás Cabrera, 1, Universidad Autónoma de Madrid, Campus de Cantoblanco, 28049 Madrid, Spain. Tel: +34 911964563; Fax: +34 911964420; Email: fhernandez@cbm.uam.es of this process good candidates for early diagnosis of the disease.
GSK3 plays a central role in neural development. In mammals, two closely related isoenzymes, GSK3a and GSK3b, are present, being the b isoform widely expressed throughout the animal kingdom, whereas GSK3a is found only in vertebrates (9) . The importance of GSK3 in neurogenesis has been demonstrated in cultured neural precursor cells (NPCs). Thus, inhibitors of GSK3 protect NPCs from apoptosis (10) and facilitate neural progenitor differentiation toward a neuronal cell type (11) . These effects are mediated by b-catenin, and interrupting b-catenin signaling reduces neural progenitor proliferation and neurogenesis by promoting the premature exit from the cell cycle and blocking maturation (12, 13) . A decrease in neurogenesis in vivo compared with wild-type (Wt) mice was observed in knock-in mice in which ser 21/9 have been mutated to alanines to block inhibitory serine-phosphorylation of GSK3a/b (14) . Alterations in adult neurogenesis have also been described in some murine models in which levels of upstream GSK-3 proteins are modified, as is the case of the fragile X syndrome mouse model. Lack of FMRP protein, which regulates specific transcription of several mRNAs including GSK-3, leads to an impairment of adult neurogenesis and to deficits in learning tasks (15) . Recently, it has been demonstrated that inhibition of the enzyme rescues not only neurogenesis but also hippocampaldepending learning (16) , highlighting the importance of GSK-3 in the process.
Immunological system regulates neurogenic population through cytokine production (17, 18) , being microglia the main effector cells in the central nervous system. Under physiological conditions, microglia protects neurons from infectious agents and plaque deposition (19, 20) . However, chronic activation of this population can be neurotoxic (21) . Besides, neuroinflammation is a common feature of most neurodegenerative disorders like AD. Thus, special attention must be paid to the factors that trigger this phenomenon. Increased GSK-3 activity contributes to generate this neuroinflammatory environment and also impairs adult neurogenesis as we have previously described in a conditional GSK-3-overexpressing mouse model (22, 23) , supporting the idea that its inhibition is a good therapy for treating neurodegenerative diseases like AD.
Here, we have further analyzed the consequences of GSK-3b overexpression on adult neurogenesis, identifying direct effects affecting the temporal expression pattern of doublecortin (DCX) marker and the localization, maturation, survival and death of these immature neurons with a remarkable impact on mature granule neurons. Simultaneously, we have identified indirect effects mediated by microglia and inflammatory molecules with deleterious consequences for neuronal precursor cells. We have also identified eotaxin as a possible mediator of these damaging effects on adult neurogenesis. Finally, taking advantage from our conditional Tet/GSK3b mouse model, we have tested whether the consequences of increased GSK3b levels are susceptible to revert after restoration of normal protein activity. Here, we show that shutdown of GSK3b overexpression reverts microgliosis and eotaxin levels and leads to normal density, localization, survival and death rates of DCX-positive precursors, normalizing also the temporal pattern expression of the marker. However, the decrease observed both in the number of neuronal precursor cells and mature neurons does not revert in doxycyclinetreated mice.
RESULTS

Transgene expression in adult developing neuronal cells
Taking into account that we are using a bi-directional promoter that allows the expression of GSK3b and the expression of a reporter gene, b-galactosidase, under the control of a postnatal promoter (CamKIIa, calcium/calmodulin-dependent protein kinase IIa), we first analyzed when the reporter (and consequently transgenic GSK3b) begins to be expressed in NPCs in the dentate gyrus (DG) of the hippocampus. Adult neurogenesis consists of different stages, starting with the proliferation of type B cells (astrocytes) that then differentiate into DCX + cells and mature into functional neurons. Thus, we tested the expression of the transgene in the different stages that characterize the process. Figure 1A -C shows that neuronal precursor cells, identified by brain lipid-binding protein (BLBP, a stage-specific marker for radial glia-like cell) in the SGZ, are not expressing b-galactosidase. Figure 1D -F shows the lack of colocalization of nuclear b-galactosidase staining with Ki-67, a nuclear marker of proliferating cells. However, we observed colocalization of DCX (a marker of immature neurons) with the reporter protein ( Fig. 1G-I ). Besides, neurons (NeuN + ) clearly resulted positive for b-galactosidase staining (Fig. 1J-L) . These data suggest that exogenous GSK3b expression first appears in DCX + cells and remains during neuron lifetime.
Doxycycline treatment is able to revert abnormalities concerning differentiating and maturating DCX 1 cells but not the decrease in mature neurons Considering that transgene expression starts during the differentiation/maturation stage (DCX + cells), we focused our attention on this particular phase of the process. We had previously demonstrated that GSK3b overexpression impairs adult neurogenesis, causing an increase of immature neurons which were found misallocated, immersed in the granular layer (GL) outside the SGZ [(23), Fig. 2 ]. Here, we have further analyzed the localization pattern of DCX + cells by quantifying the number of these cells per zone of the GL (see Materials and Methods). This allowed us to confirm that Tet/GSK3b mice show alterations in the differentiation/ maturation stage.
Then, we decided to explore whether these alterations were susceptible to revert by shutting down the transgenic system. Six weeks of doxycycline treatment restores normal GSK3 levels and activity in Tet/GSK3b mice (24) . In our case, 2.5-month-old doxycycline-treated animals (Gene-OFF group) showed normal values of DCX + cell density (similar to Wt) and a recovery in the localization pattern of these cells, tending to re-organize them in zone 1 as observed in the Wt group ( Fig. 2A -G) .
Next, we tried to find a possible explanation for the abnormal density and localization of DCX + precursors in Tet/ Fig. S1 ). Thus, we hypothesized that, maybe, problems in temporal expression pattern of DCX marker could account for the alterations observed in the transgenic mice. To validate this hypothesis, we injected animals with thymidine analogues and analyzed the percentage of newborn neurons that were positive for DCX staining at different time points. At 2 h post-injection, the expression of DCX is already visible (26), so we would be able to detect problems in the switching-on of the marker by studying the 72 h post-injection time point. In this case, the percentage of CldU + /DCX + cells found in the Gene-ON group was similar to that found in the Wt group (Fig. 2H) . 
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Human Molecular Genetics, 2013, Vol. 22, No. 7 Between the fourth and seventh day after the injection with thymidine analogues, the maximum percentage (90%) of labeled newborn neurons expressing DCX is reached. Thereafter, DCX expression is rapidly downregulated. Expression levels are minimum by 4 weeks and become undetectable by 2 months after labeling (26) . Taking this into account, we analyzed later time points in order to detect a possible delay in the switching-off of DCX marker. At 3 weeks of cell age, the percentage of IdU + /DCX + cells was not altered either (Fig. 2H) . However, when we analyzed the 6-week time point in another group of animals, we observed that Tet/GSK3b showed a significant increase in the number of IdU + cells that were also positive for DCX staining, pointing to a delay of the switching-off of the marker. Besides, when these animals were treated with doxycycline for 6 weeks, the normal numbers observed in Wt mice were restored (Fig. 2I) .
Considering all the alterations concerning DCX + cells in transgenic mice, we decided to evaluate other factors that could be affecting this population. We then analyzed the survival and death rate of these cells. By counting the total number of 6-week-old cells, we found an increase of those in Gene-ON group compared with the Wt group. Furthermore, we observed that this abnormal survival rate was reverted in Gene-OFF group (Fig. 3A -E) . Death rate was evaluated by immunostaining with the anti-fractin antibody, which labels actin fragments cleaved by caspase-3 (Fig. 3F) . As is observed in Figure 3E , the number of fractin + cells/mm 3 in the GL was significantly higher in GSK3b-overexpressing mice, as we had previously demonstrated (27) . Besides, this neuronal death was reverted with doxycycline treatment. Curiously, when we explore the specific death of DCX + cells, we found that, in this case, the percentage of those that were colabeled with fractin was diminished in Tet/GSK3b animals and again, that this alteration was reverted in the doxycycline-treated mice (Fig. 3E) . Finally, we evaluated the impact of the alterations found in the survival and death rates by estimating the mature neuron density (see Materials and Methods). The results indicate that Gene-ON mice show a decrease in mature neurons compared with the Wt as we have previously described (27) and also, and more interesting, that this is not recovered in Gene-OFF mice (Fig. 3E) .
Next, we decided to study other characteristic markers of the maturation process. Thus, we performed a triple immunofluorescence staining with the antibodies that recognize the proteins DCX, calretinin (CR; which labels postmitotical immature neurons) and NeuN (marker of mature neurons), finding that the percentage of immature neurons (DCX + / CR + cells) that were also positive for NeuN staining was significantly decreased in Tet/GSK3b mice and restored with doxycycline treatment (Supplementary Material, Fig. S2 ). This allowed us to confirm the aforementioned maturation problems observed in transgenic animals.
Therefore, GSK3b overexpression causes alterations not only in the density and localization of DCX + cells but also in the temporal pattern expression of this marker and in the survival and death rate of these cells, resulting in a specific loss of mature neurons. Doxycycline treatment is able to restore all these alterations except from the normal total number of mature neurons in the GL.
Finally, we studied some of the observed abnormalities concerning DCX precursor cells over time. We then analyzed animal groups from different ages (Fig 4) . Interestingly, at 1 month of age, we did not detect any significant differences in the density of DCX + cells, although it was possible to observe a tendency to increase in transgenic mice. At 4.5 months of age, we detected the same alterations described for 2.5-month-old animals, including misallocation of immature neurons in the GL (Supplementary Material, Fig. S3 ). In this case, doxycycline treatment reduced DCX + cell density (Fig. 4) , although not significantly, and restored normal localization pattern of these cells (Supplementary Material, Fig. S3 ).
All these data suggest that alterations in the differentiation/ maturation stage become evident at 2.5 months of age and are susceptible to revert mainly in younger animals.
Alterations in neuronal precursor cell density and disorganization of neurogenic niches in the DG are not restored in Gene-OFF Tet/GSK3b mice.
Although transgenic GSK3b is not being expressed in NPCs, previous work demonstrated alterations in neurogenic niches in our mouse model (23) . Therefore, we tested the effects of doxycycline treatment on this population. Nestin is an intermediate filament that labels neuronal precursor cells which are also positive for GFAP staining (Fig. 5A ). When we analyzed the density of Nestin + cells in 2.5-month-old Tet/GSK3b mice, a decrease was observed (31+17.5% decrease compared with Wt mice; Fig. 5B ), confirming previous data pointing to an impoverishment of neurogenic niches. Surprisingly, 6 weeks of transgene shutdown did not restore normal levels. When we studied Nestin population over time, we again observed that differences between Wt and Tet/GSK3b mice were not detectable at 1 month of age. However, in 4.5-month-old animals, we were able to quantify a decrease in Nestin + cell density as observed at 2.5 months, and again, this was not reversible with doxycycline treatment (Fig. 5B) .
We then decided to further explore the organization and composition of neurogenic niches in the older group. To carry out that analysis, the number of type B cells (astrocytic cells) and niches was determined in the SGZ in toluidine-blue semithin sections. Type B cells were recognized by their pale cytoplasm and nucleus, which frequently appears irregularly shaped. Type D cells (amplifying precursor cells) were identified by their dark nucleus and cytoplasm, as well as by their shape and location. On the other hand, mature neurons appeared very different, mainly by their characteristic bigger and rounded nuclei. Neurogenic niches were considered as the minimal association of one astrocytic cell with a type D cell or two astrocytic cells with two to four type D cells.
In the 4.5-month-old Gene-ON group, a reduction in the number of astrocytes and neurogenic niches was observed ( Fig. 5C and D) . Doxycycline treatment during 6 weeks was not able to revert either neurogenic niches or astrocytes toward normal levels. These data suggest a permanent effect in progenitor cells and a premature depletion of neurogenic niches similar to that in aged mice.
In panoramic views of toluidine blue-stained semithin sections, we observed the overall cell organization in the DG. Although the Gene-ON group presented a disorganized, irregular
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and thinner GL, in the Gene-OFF group, it appeared thicker and more organized, which could be due to the recovered neural maturation previously described (Fig. 6 A, E and I). Cellular niches were clearly identified in the SGZ; they not only diminished in number in Gene-ON and Gene-OFF groups, as previously described in young mice, but we also detected an impoverishment of their composition. Most of them contained only two astrocytes or one astrocyte and one type D cell in contrast to the Wt group, in which neurogenic niches usually contain one to two astrocytes and two to four type D cells (Fig. 6 A, E and I). Besides, abundant microglial cells near the SGZ were observed only in the Gene-ON group (Fig. 6E) .
To complete the study of neurogenic niche composition and confirm previous data, ultrathin sections were analyzed by electron microscopy (EM). At EM, astrocytes were unequivocally identified by their irregular contour, smooth chromatin and light cytoplasm containing GFAP filaments and type D cells by their regular contours, intercellular spaces dark cytoplasm and clumped chromatin (Fig. 6 ). Qualitative analysis confirmed the impoverishment in cell composition in Gene-ON and Gene-OFF groups previously described. Interestingly, lipofuscin accumulations were frequently observed in astrocytes of the Gene-OFF group (Fig. 6K) , similar to those observed in aged mice.
Thus, GSK3b overexpression seems to affect indirectly neuronal precursor cells altering neurogenic niche composition and causing a depletion of this cell population in a nonreversible manner at analyzed ages. 
Reversal of microgliosis and eotaxin levels in the hippocampus of Gene-OFF Tet/GSK3b mice
We have previously demonstrated that in vivo overexpression of GSK3b results in microgliosis in the hippocampal DG of Tet/GSK3b mice, especially in the SGZ (Fig. 7B , arrows) (22, 23) . As overexpression starts at the differentiation/maturation stage (DCX + cells) and transgenic mice show alterations in Nestin + cell density and in neurogenic niche composition (not expressing b-galactosidase), we hypothesized that neuroinflammation could be responsible, in some way, for those damaging effects found in the neuroprecursor cell population.
Qualitatively, microglial cells in the Gene-ON group appear activated due to their increase not only in number but also in their soma size. Interestingly, 6 weeks of transgene shutdown resulted in full reversal of the microgliosis as evidenced by immunohistochemical detection with the antibody Iba-1 ( Fig. 7A-C) . Quantitatively, a significant increase in the number of microglial cells/mm 3 is observed in the Gene-ON group, which significantly decreases in the Gene-OFF group (P , 0.05). No significant differences were observed between the Wt and the Gene-OFF group.
In order to further investigate the molecular mechanisms underlying the neuroinflammatory environment, a mouse cytokine array (Array III; Ray Biotech, Inc., Norcross, GA, USA) consisted of 62 different soluble signaling factors and cytokine antibodies was tested. Although some changes were found in different pro-and anti-inflammatory cytokines among analyzed groups (Supplementary Material, Fig. S4 ), we focused our attention on eotaxin (CCL11; eotaxin-1), a small chemokine known by its implication in allergic responses and recently linked to adult neurogenesis and aging (28) . Quantification revealed a dramatic increase in eotaxin levels in 2.5-month-old Tet/GSK3b mice (92.99% increase in the Gen-ON group compared with the Wt group). Doxycycline-treated mice presented a significant recovery, showing similar levels to those found in the control group (Fig. 8) .
Therefore, microglia and neuroinflammatory mechanisms mediated in part by eotaxin could be responsible, in part, for adult neurogenesis alterations in GSK3b-overexpressing mice. Both microgliosis and abnormal eotaxin levels are reversible after doxycycline treatment.
DISCUSSION
In this study, we have found that restoring increased GSK3b activity to basal levels has consequences on adult neurogenesis. Thus, our data support the idea that the increase and abnormal localization of immature neurons (DCX + cells) as well 1306
as the alterations in the time pattern expression of DCX and in the survival and death of these cells in Gene-ON Tet/GSK3b mice are susceptible to revert after restoring normal GSK3 levels. This is not the case for granule neurons and for NPCs, since in Gene-ON mice, both the decrease in number of mature neurons and the reduction in Nestin + cell density as well as the impoverishment in neurogenic niches (fewer and more disorganized) are not reversible after doxycycline treatment.
These data reflect another important finding in this study; GSK-3 has dual effects on adult neurogenesis. Taking into account that transgene expression is first observed in the differentiation/maturation phase (DCX + cells) and not in earlier stages and that, however, alterations of the process are found affecting not only DCX + cell population but also neuroprecursor cells, it is likely to think that increased GSK3b activity may be having indirect and direct consequences on adult neurogenesis.
Previously, it had been demonstrated that GSK3b overexpression impairs adult neurogenesis (23) . Here, we have further analyzed those alterations, finding important changes concerning the differentiation of newborn neurons and providing important data supporting the idea of a blockade in the maturation process. In this regard, Spittaels et al. (29) previously demonstrated that GSK-3b influences post-natal maturation and differentiation of neurons in vivo in transgenic mice that overexpress a constitutively form of the enzyme. Here, we have confirmed this and we prove for the first time that GSK3b regulates not only post-natal neurogenesis in the DG but also adult neurogenesis. A possible mediator of these effects could be b-catenin, one of the main GSK3b targets. It is known that the lack of b-catenin reduces neural progenitor proliferation and neurogenesis by blocking maturation (12, 13) . The importance of Wnt signaling pathway (in which b-catenin participates) in adult neurogenesis was also highlighted by Lie et al. (30) , who demonstrated that stimulation of this pathway was able to induce neurogenesis both in vivo and in vitro. More recently, Kumamoto et al. (31) have defined a role for Wnt and b-catenin in the dendrite refinement and synaptic integration of newborn neurons. In this work, they report that deletion of primary cilium (a highly specialized sensory organelle important during development and adult homeostasis) enhances Wnt and b-catenin signaling and that this decreases dendritic length and branching of newborn neurons. Thus, in this case, inhibition of GSK-3 as a consequence of Wnt activation would be deleterious. Nevertheless, the stimulation of this pathway seems to occur as a compensatory mechanism emerging after primary cilium deletion. Here, we do not have any evidence that persistent increased activity of GSK-3 shown by our transgenic animals affects primary cilium but, as our main findings demonstrate, it leads to alterations in survival and death of newborn neurons as well as in the expression pattern of DCX marker and in the maturation process. Consequently, it is probably that GSK-3 has different effects depending on the context and the stimulus triggering its activation or inhibition. Besides, it is important to note that the inflammatory environment created by GSK3b overexpression might be also contributing to impair the formation of new neurons as other groups have previously reported (32, 33) . Abnormal density of DCX + cells and their misallocation along the GL would confirm the aforementioned maturation blockade. Importantly, we have provided data that explain, in part, that accumulation. First, we have proved that the proliferation rate remains unchanged in Tet/GSK3b mice as demonstrated by the PH3 + cell counting. By injecting thymidine analogues at different time points, we have found that the temporal pattern expression of DCX marker is altered in transgenic mice. These alterations seem to affect the switching-off but not the switching-on of the marker as evidenced by the increase of 6-week-old IdU + /DCX + cells and the lack of changes at 72 h and 3 weeks. Direct GSK3b overexpression could be responsible for this delay in the switching off of DCX. Indeed, DCX has been recently described as a novel substrate for the enzyme, which is able to phosphorylate it in Serin 321 both in HEK293 cells and in cultured neurons (34) .
On the other hand, we have observed an increase in the survival rate of 6-week-old immature neurons. At the same time, immunostaining with fractin antibody has enabled us to confirm that DCX + cells die less in the Gene-ON group than in the Wt group. Considering all these data, it is likely to think that the excess in DCX + cells as well as their misallocation in the GL could be the result of the combination of all these effects: an increase in the survival rate of immature neurons, a decreased cell death affecting these precursors and a delay in the switching-off of the DCX marker. Thus, most of these cells would correspond to neurons that, having reached their final position within the GL, should have switched off the marker. This would explain their abnormal localization pattern. 
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Furthermore, it is noteworthy to highlight that, contrary to the results concerning specific death of DCX + cells, the general rate of death in DG is higher in Tet/GSK3b mice as previously described (27) . Besides, when we analyzed the total number of mature neurons, we found a significant decrease in transgenic animals. GSK-3 has been largely demonstrated to induce apoptosis by simply overexpressing the gene (35) and under several conditions, such as the deprivation of trophic factors (36) , the inhibition of the PI3K/Akt pathway (37), the DNA damage (38) , the endoplasmic reticulum stress (39) and the Ab-induced neurotoxicity (40) . Besides, lithium, a selective inhibitor of the kinase, has been reported to be neuroprotective (41) . Considering this, it is likely to think that GSK-3-induced apoptosis may account for the decreased granule neuron density observed in our transgenic mouse model. Here, we have also reported that in GSK-3-overexpressing mice, the DCX cell population shows, however, a lower death rate together with a higher survival rate comparing with the Wt and consequently, an increase in their number. Since the final result is the diminution in the granule neuron density and the previously reported atrophy of the DG (23, 42) , we hypothesized that the excess in abnormal differentiating DCX + cells may be eliminated in the later stages of the maturation process as a consequence of their aberrant maturation which was ultimately triggered directly or indirectly by GSK-3. Indeed, it has been proposed that adult neurogenesis regulation seems to be a Hebbian mechanism, by which the cells that are functionally beneficial survive while the others die (43) . Apoptosis and cell death are accompanied by glial alterations such as reactive astrocytosis and microgliosis (22) . In agreement, by toluidine staining, we have been able to observe how microglial cells in Tet/GSK3b mice accumulate near the SGZ, suggesting a possible role for them on neurogenic niches, as others authors have previously described (44) . Doxycycline administration reverts all these alterations concerning immature neurons, a fact that could explain, in part, the reversion of learning and memory deficits previously found in Tet/GSK3b mice (24) . Interestingly, reversion of specific DCX + cell death and survival also explains the normal density of these precursors and the recovery of their localization pattern in the Gene-OFF group.
However, the age of the animals seems to be an important factor to keep in mind. Thus, at 4.5 months of age, although the abnormal localization pattern is significantly reverted, results for increased DCX + cell density are not so evident. This lack of a full reversal phenotype in these animals could be a consequence of the marked loss of NPCs and mature neurons caused by the increase of the kinase over time.
GSK3b overexpression results in a depletion of neurogenic niches (23) . Here, we have found that the loss of NPCs affects especially Nestin + cells, correlating with the decrease in astrocytes (type B cells) quantified by toluidine staining in semithin brain sections. Overall niche organization and composition as well as lipofuscin aggregates evidence a premature aging phenotype in Tet/GSK3b mice. However, transgene expression is not found in these cells as we have demonstrated by colocalization with specific markers. This proves that indirect factors derived from GSK-3 overexpression must be taking part in the NPC population alterations described in this transgenic model. Therefore, we focused our attention on neuroinflammation, a widespread phenomenon in neurodegenerative diseases characterized by chronic activation of microglia and production of proinflammatory cytokines with a relevant influence on adult neural stem cell regulation and function (45) .
Following previous results, we confirmed an increase in reactive microglia in the Gene ON Tet/GSK3ß group that was reverted by 6 weeks of doxycycline treatment. Microglia activation can be detrimental for adult neurogenesis (reviewed in 46). Its activation would be contributing to generate an inappropriate environment not only for NPCs development but also for differentiating precursors that, as result of a combination of negative factors (GSK-3 overexpression and microgliosis), would show an impaired maturation. Besides, by performing a cytokine array, we were able to determine that a neuroinflammatory environment is evident in our transgenic mouse model. Interestingly, levels of a particular cytokine, eotaxin-1 (or CCL11), were found dramatically increased in the Gene-ON group compared with the Wt group, and more importantly, they returned to normal levels in the Gene-OFF group. Eotaxin has been recently linked to adult neurogenesis. Thus, levels of this molecule are elevated in the plasma of mice during normal aging. Besides, this chemokine is able to impair neurogenesis when administered systemically to young mice, producing as a consequence, learning and memory deficits (28) . Furthermore, eotaxin seems to affect directly the number and size of neurospheres formed from primary NPCs (28) , suggesting that precursor cells probably have receptors capable of binding the cytokine. This could explain in part the alterations observed in neurogenic niches in our transgenic model, in which activation of neuroinflammatory response as a consequence of GSK-3 overexpression results in an increase of reactive microglia and probably in a recruitment of immune cells, elevating, among others, eotaxin levels in the brain.
Alternatively, we cannot rule out that other mechanisms could account for the marked loss of precursor cells observed in transgenic mice. The alterations in some of the stages of the adult neurogenesis process might be having an impact on the NPC population, in agreement with the fact that adult neurogenesis regulation must be considered as a whole, occurring at different levels which cannot be understood individually (43) . In this regard, the increased apoptosis affecting granule neurons as a consequence of GSK-3 overexpression could be contributing to deprive NPCs of important factors for their maintenance and survival. Among factors that are produced by neurons, insulin-like growth factor-1, bone morphogenetic proteins and brain-derived neurotrophic factor (BDNF) have been reported to influence or regulate adult neurogenesis (47 -49) . Consequently, a deregulation of normal levels of these trophic factors, also potentiated by the neuroinflammatory environment, could be leading to the progressive decline in NPCs as well as to the impoverishment of neurogenic niches reported in Tet/GSK-3b mice. In relation to this idea, it is noteworthy to consider the importance of the vascular niche in adult neurogenesis (50) , which mediates the supply of circulating factors also important for the process. Similarly, NPCs could be indirectly affected by the GSK-3-induced alterations in neurotransmission. This kinase has been widely demonstrated to regulate and mediate the cross-talk between the two major forms of synaptic plasticity, the longterm potentiation (LTP) and the long-term depression (reviewed in 51). Thus, its activation in rat hippocampus inhibits LTP with synapse-associated impairments (52), in agreement with the results obtained in our transgenic mouse model, in which LTP is impaired in the hippocampal region, being reversible after lithium treatment (53) . In this regard, there is evidence that links alterations in neurotransmission at this level to adult neurogenesis (54) . Interestingly, LTP is associated with the release of several proteins including neurotrophic factors such as BDNF (55) . Besides, an imbalance between GABAergic and glutamatergic transmission has been shown to impair neurogenesis in a mouse model of AD (56) . Considering all these findings, we speculate that impairment in LTP could be having detrimental consequences on NPC population in Tet/GSK-3b mice. Finally, it is likely that all these possible scenarios, with a great importance of neuroinflammation and its consequences, could be taking place simultaneously in our transgenic model, creating a non-permissive environment for the maintenance and survival of the adult neural progenitor cells.
Our main finding, however, highlights the idea of an irreversible recovery of neuronal precursor population. Thus, doxycycline was unable to restore normal Nestin + cell density and the number of astrocytes (type B cells). The reduction in neurogenic niches and their altered composition was not recovered either, despite restoring normal microglia and eotaxin levels. This suggests that, once the loss of neuronal progenitor cells occurs by detrimental stimulus as in this case, increased GSK-3 activity, a permanent and irretrievable damage, remains in the hippocampus. Similarly, we do not observe any recovery in relation to the observed loss of mature neurons in transgenic mice, which could be a direct consequence of the inability to recover the NPC population.
Neurogenesis is altered in certain acute neurological disorders, such as ischemia and epilepsy (57) , as well as in some chronic neurodegenerative disorders as AD (reviewed in 58). In particular, controversial data exist about how neurogenesis is affected in mice models of this dementia. In humans, an increase in DCX + cells as well as in other adult neurogenesis markers has been reported (8) . However, it is not fully understood whether those precursor cells eventually become fully mature neurons. In contrast, taking into account our results obtained in Tet/GSK3b mice, we think that the increase in immature neurons does not really reflect an increase in adult neurogenesis, but on the contrary, a blockade of maturation and consequently, an impairment of the process. Also, special attention must be paid to neuroinflammation, a phenomenon that is becoming of great importance for its implication not only in neurodegeneration but also in adult neurogenesis (45) . Neuroinflammation has been proposed as a possible cause or driving force of AD, due to the several inflammatory mediators found in postmortem brains of patients (reviewed in 59). Regarding eotaxin, there is evidence that links this molecule to the disease. On the one hand, it is noteworthy to consider that levels of this cytokine in plasma and cerebrospinal fluid increase with age in healthy humans, correlating with the decrease in the rate of neurogenesis and the concomitant reduction in cognitive ability (28) . On the other hand, levels of eotaxin are found to be specifically increased in serum from AD patients (60) . At the same time, the expression of its receptor, CCR3, is also augmented in AD brains, especially in reactive microglia (61) , maybe exacerbating its detrimental role on adult neurogenesis.
Considering direct and indirect effects of increased GSK-3 activity on adult neurogenesis, leading in this mouse model to DG atrophy and to deficits in learning and memory (42) , inhibitors of the kinase emerge as an appropriate pharmacological tool to treat these alterations. Indeed, they have been proposed as a treatment for AD (62) where abnormal increases in GSK3 levels and activity have been associated with neuronal death, paired helical filament tau formation and neurite retraction as well as a decline in cognitive performance. In fact, GSK3 inhibition prevents tau pathology in AD mouse models (24) , although is not able to change back tau filaments already aggregated (63) . Our data strongly support the notion that GSK3 inhibitors could be useful to prevent not only protein toxicity but also abnormal neuronal precursor maturation as well as neuroinflammation and its consequences. In this sense, inhibition of the enzyme would restore microglia to normal conditions and they would regulate levels of harmful cytokines as eotaxin. However, special consideration should be taken in the timing of administration of these drugs, since once depletion of neuronal precursor cells happen, they would result ineffective. An open question is when these processes can be reverted. Although further studies must be performed in this respect, it is reasonable to speculate that the use of GSK-3 inhibitors could be adequate in early stages of AD, whereas in later stages, combination with neuronal precursor replacement therapies would prove more effective. In fact, memory improvements have been described after neuronal precursor transplantation in an inducible mouse model of neuronal loss (64) .
In summary, restoring GSK3 activity to basal levels could have a therapeutic benefit in neurodegenerative disorders like AD by reversing aberrant neurogenesis. However, impaired adult neurogenesis induced by increased GSK3 activity is susceptible to revert only partially after restoration of normal GSK3 levels. Thus, neuronal precursor loss cannot be reverted, reflecting a permanent damage in the hippocampus. An open question is whether such damage is also irreversible in other neurodegenerative processes or is only observed in GSK3-related diseases.
MATERIALS AND METHODS
Animals
Mice were bred at the Centro de Biología Molecular 'Severo Ochoa' animal facility. Mice were housed four per cage with food and water available ad libitum and maintained in a temperature-controlled environment on a 12/12 h light/dark cycle with light onset at 7 a.m. Tet/GSK3b mice were generated as previously described (22) . Briefly, Tet/GSK3b mice (Gene-ON) result from the breeding of TetO mice (carrying the bidirectional Tet-responsive promoter followed by GSK3b and b-galactosidase cDNAs, one in each direction) with CaMKIIa-tA mice. The Tet/GSK3b mice overexpress GSK3b in cortical and hippocampal neurons in a conditional manner repressible by the administration of the tetracycline analogues doxycycline. Wt animals resulting from crossing TetO line with C57/BL6 mice were used as the control group.
Doxycycline treatment
Tet/GSK3b and its control littermates were given doxycycline (2 mg/ml; Sigma-Aldrich, St Louis, MO, USA) in drinking water ad libitum during 6 weeks starting at different ages (1 month and 3 months; Gene-OFF group) (24) . All animals were handled in strict accordance with good animal practice as defined by the national animal welfare bodies (Universidad Autónoma de Madrid and CSIC, the Spanish Scientific Research Council).
Injection of thymidine analogues
5-Chloro-2
′ -deoxy-uridine (CldU, 57.65 mg/kg i.p., Sigma-Aldrich) and 5-iodo-2 ′ -deoxy-uridine (IdU, 42.75 mg/kg i.p., Sigma-Aldrich) were administered to animals at different time points (6 weeks, 3 weeks or 72 h prior to sacrifice). For the 6 and 3 week time point, IdU was injected once a day during 4 consecutive days. For the 72 h time point, animals were injected with a single dose of CldU. IdU and CldU doses were based on equimolar doses of 50 mg/kg BrdU as previously described (65) .
Tissue processing
Animals were anesthetized and perfused intracardially with 0.9% saline followed 4% paraformaldehyde (PFA). The brain was removed and postfixed overnight in 4% PFA, and 30 mm sagittal sections were obtained on a vibratome. For EM, animals were perfused with 0.9% saline followed by 2% PFA and 2.5% glutaraldehyde. Their brains were removed and postfixed overnight in the same fixative, and 200 mm coronal sections were obtained and processed for EM (see what follows).
Immunofluorescence and immunohistochemistry
Immunofluorescence was performed using the following primary antibodies: mouse anti-b-galactosidase (1:5000, Promega); rabbit anti-BLBP (1:200, Abcam); polyclonal rabbit anti-nuclear Ki-67 (1:500, Novocastra); goat anti-DCX (1:500, Santa Cruz, CA, USA); mouse anti-NeuN (1/500, Millipore); rat anti-BrdU/CldU (1:400, Accurate Chemical & Scientific Corporation); mouse anti-IdU (1:500, BD Biosciences); rabbit anti-fractin (1:500, BD Pharmingen); mouse anti-nestin (1:100; BD Biosciences, NJ, USA); rabbit anti-GFAP (1:500, Promega); rabbit anti-CR (1:200, Swant); rabbit anti-phospho-histone H3, Serin 10 (PH3) (1:250, Millipore). The binding of these antibodies over 24-48 h was detected by incubating for 24 h at 48C with the appropriate donkey Alexa-conjugated secondary antibodies (1:500, Molecular Probes, Eugene, OR, USA). All the sections were finally counterstained for 10 min with DAPI (1:1000, Calbiochem-EMD Darmstadt, Germany). For immunohistochemistry, brain sections were incubated with primary antibody, rabbit anti-Iba-1 (1:500, Wako Pure Chemical Industries), for 24 h and then incubated in avidin-biotin complex, using the Elite Vectastain kit (Vector Laboratories, Burlingame, CA, USA). Chromogen reactions were performed with diaminobenzidine (Sigma) and 0.003% H 2 O 2 for 10 min. Sections were coverslipped with Fluorosave.
Cell counting
The density of immature neurons (DCX + cells) was calculated using the physical-dissector method adapted for confocal microscopy (Zeiss LSM710), as described elsewhere (66) . Four stacks of images were analyzed per animal. Data are shown as DCX + cells/mm 2 . To study the localization of DCX + cells, two immunofluorescence images were obtained per section and animal with a ×40 objective (to get a composition of the overall DG structure), using a LSM710 Zeiss confocal microscope. In the images, the GL was divided into four regions or zones of 14.47 mm width (the approximate size of a DCX + cell soma), being zone 1 adjacent to the SGZ and zone 4 the most separated one respect to it (including all cells located beyond zone 3). Six-week-old IdU + cells were counted under an inverted Axiovert200 Zeiss fluorescence microscope (×40 oil immersion objective), using the optical dissector method (67) . Briefly, series composed of every eighth section were used to analyze each of these markers, the cells labeled for each marker in every section were counted and the total number of cells counted was then multiplied by 8 in order to obtain the total number of cells.
The density of mature granule neurons (number of cells/ mm 3 ) was analyzed through the application of a physicaldissector method developed for confocal microscopy (Zeiss LSM710), as described previously (66 . The number of positive cells for each marker was divided among each section's DG volume in order to obtain a cell density. The DG area of each section was estimated delineating the border of the GL on the same sections where cell numbers were estimated by using DAPI staining and a ×5 objective. Data are presented as mean cell density (cells/mm 3 ). All DG areas were measured using the Image J software (ImageJ, v. 1.33, NIH, Bethesda, MD, USA, http://rsb.info.nih.gov/ij).
Tissue processing for semithin sections and EM
Coronal sections (200 mm), corresponding to the same hippocampal region, were postfixed in 2% osmium tetroxide (OsO 4 ) for 2 h, rinsed, dehydrated and embedded in Durcupan (Durcupan, Fluka). To study the overall organization of the DG and the number of niches, serial semithin sections (1.5 mm) were cut with a diamond knife and stained with 1% toluidine blue. Subsequently, the area of interest was trimmed, and ultrathin sections (50 -70 nm) were obtained from this material with a diamond knife, which was stained with lead citrate and examined under a Fei Tecnai Spirit electron microscope. Niche quantification was carried out on 15 serial semithin sections per mouse. Data are reported as the means (+SEM) of the number of niches and astrocytes/stem cells per slice in the DG.
Chemokyne high-density antibody array
Hippocampi were lysed and protein concentration was estimated using BCA Protein Assay Kit (Pierce, Rockford, IL, USA). Mouse cytokine array (Array III; Ray Biotech, Inc., Norcross, GA, USA) consisted of 62 different soluble signaling factors and cytokine antibodies spotted in duplicate onto a PVDF membrane. The experiment was performed in three separated membranes (one per experimental group). An amount of 250 mg of protein was used per membrane, mixing an equivalent amount of protein from each animal (seven animals; 37.5 mg/animal). The membranes were blocked with 10% bovine serum albumin in PBS and subsequently incubated overnight at 48C. The membranes were washed with wash buffer supplied by the manufacturer, exposed to 500-fold diluted biotin-conjugated anti-cytokine antibodies at room temperature for 2 h, washed and incubated with a 1000-fold diluted HRP-conjugated strepavidin for 1 h and immersed for 1 min in peroxidase substrate solution. For each spot, the net density gray level was normalized by subtracting the background gray levels from the total raw density gray levels, using the Chemidoc XRS system and Quantity One image analysis software (Bio-Rad, UK).
Statistical analysis
Comparisons between groups were performed by one-way ANOVA. P , 0.05 values were considered significant. The SPSS 17.0.1 software (SPSS, 1989; Apache Software Foundation) was used for all statistical analyses. For qualitative analysis (colocalization studies), a x 2 test was performed.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
